Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Operating Expenses (2016 - 2020)

Historic Operating Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to $8.7 million.

  • Forte Biosciences' Operating Expenses fell 4847.75% to $8.7 million in Q1 2020 from the same period last year, while for Dec 2020 it was $8.7 million, marking a year-over-year decrease of 8586.93%. This contributed to the annual value of $61.5 million for FY2019, which is 366.57% down from last year.
  • Per Forte Biosciences' latest filing, its Operating Expenses stood at $8.7 million for Q1 2020, which was down 4847.75% from $10.7 million recorded in Q4 2019.
  • In the past 5 years, Forte Biosciences' Operating Expenses ranged from a high of $19.1 million in Q4 2018 and a low of $7.6 million during Q1 2016
  • Its 5-year average for Operating Expenses is $12.0 million, with a median of $10.7 million in 2017.
  • As far as peak fluctuations go, Forte Biosciences' Operating Expenses skyrocketed by 7872.1% in 2018, and later tumbled by 4847.75% in 2020.
  • Quarter analysis of 5 years shows Forte Biosciences' Operating Expenses stood at $8.0 million in 2016, then soared by 33.95% to $10.7 million in 2017, then surged by 78.72% to $19.1 million in 2018, then tumbled by 43.97% to $10.7 million in 2019, then decreased by 18.8% to $8.7 million in 2020.
  • Its Operating Expenses stands at $8.7 million for Q1 2020, versus $10.7 million for Q4 2019 and $17.1 million for Q3 2019.